Announce Date | 05/01/2024 |
EPS Normalized Actual | $0.31 (Beat by $0.2) |
EPS GAAP Actual | $0.31 (Beat by $0.2) |
Revenue Actual | $0.634B |
Revenue Surprise | Beat by $634M |
Announce Date | 07/01/2024 (Pre-Market) |
EPS Normalized Estimate | $0.13699 |
EPS GAAP Estimate | $0.13699 |
Revenue Estimate | $0.682300263B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 1.35 | 18.87 | 1.32032 | 1.4014 | 1 |
Dec 2027 | 1.25 | 20.38 | 1.22252 | 1.29759 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ3 2022 (Sep 2022) | 0 | 0 | 0.634B | -13.56% | 634M |
FQ2 2022 (Jun 2022) | 0 | 0 | 0.627B | -4.94% | 627M |
FQ1 2022 (Mar 2022) | 0 | 0 | 0.612B | -11.27% | 612M |
FQ4 2021 (Dec 2021) | 0 | 0 | 0.82B | -0.73% | 820M |
FQ3 2021 (Sep 2021) | 0 | 0 | 0.72B | 0.14% | 720M |
FQ2 2021 (Jun 2021) | 0 | 0 | 0.658B | 1.22% | 658M |
FQ1 2021 (Mar 2021) | 0 | 0 | 0.681B | 14.39% | 681M |
FQ4 2020 (Dec 2020) | 0 | 0 | 0.826B | 100% | 826M |
FQ4 Announce Date
07/01/2024 (Pre-Market)
Consensus EPS Estimates
0.13699
Consensus Revenue Estimates
0.682300263B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2025 (Oct 2025) | 0.22 | -- | 0.21338 | 0.22509 | 1 |
FQ3 2025 (Jul 2025) | 0.18 | -- | 0.17458 | 0.18417 | 1 |
FQ2 2025 (Jun 2025) | 0.175 | -- | 0.16912 | 0.17936 | 1 |
FQ1 2025 (Mar 2025) | 0.145 | -- | 0.14013 | 0.14861 | 1 |
FQ4 2024 (Oct 2024) | 0.19832 | -- | 0.17943 | 0.20776 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2025 (Oct 2025) | 0.75B | -- | 0.73B | 0.76B | 0 |
FQ3 2025 (Jul 2025) | 0.73B | -- | 0.71B | 0.74B | 0 |
FQ2 2025 (Jun 2025) | 0.71B | -- | 0.7B | 0.73B | 0 |
FQ1 2025 (Mar 2025) | 0.68B | -- | 0.66B | 0.69B | 0 |
FQ4 2024 (Oct 2024) | 0.73B | -- | 0.71B | 0.74B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
0
EPS # of in-lines
8
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2022 (Sep 2022) | 0 | 0 | NAN% | |
FQ2 2022 (Jun 2022) | 0 | 0 | NAN% | |
FQ1 2022 (Mar 2022) | 0 | 0 | NAN% | |
FQ4 2021 (Dec 2021) | 0 | 0 | NAN% | |
FQ3 2021 (Sep 2021) | 0 | 0 | NAN% | |
FQ2 2021 (Jun 2021) | 0 | 0 | NAN% | |
FQ1 2021 (Mar 2021) | 0 | 0 | NAN% | |
FQ4 2020 (Dec 2020) | 0 | 0 | NAN% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2022 (Sep 2022) | $0B | $0.63B | $634M | 100% |
FQ2 2022 (Jun 2022) | $0B | $0.63B | $627M | 100% |
FQ1 2022 (Mar 2022) | $0B | $0.61B | $612M | 100% |
FQ4 2021 (Dec 2021) | $0B | $0.82B | $820M | 100% |
FQ3 2021 (Sep 2021) | $0B | $0.72B | $720M | 100% |
FQ2 2021 (Jun 2021) | $0B | $0.66B | $658M | 100% |
FQ1 2021 (Mar 2021) | $0B | $0.68B | $681M | 100% |
FQ4 2020 (Dec 2020) | $0B | $0.83B | $826M | 100% |